The Unusual Clinical Profile of Three Brothers With Cystic Fibrosis Warrants a New Look at Standard CF Care
source: pixabay.com

The Unusual Clinical Profile of Three Brothers With Cystic Fibrosis Warrants a New Look at Standard CF Care

  Science Direct recently published a Respiratory Medicine Case Report that may impact future Cystic Fibrosis (CF) treatment. The case involves adult brothers herein referred to for purposes of this…

Continue Reading The Unusual Clinical Profile of Three Brothers With Cystic Fibrosis Warrants a New Look at Standard CF Care
TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
Source: https://unsplash.com/photos/ZHys6xN7sUE

TAVNEOS Approved in Japan for ANCA-Associated Vasculitis

Sometimes, certain drugs may be approved in different countries and not in others. However, drug approval spanning multiple countries highlights the importance of getting drugs and treatments into the hands…

Continue Reading TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
Nucala Recommended for Three New Indications
stevepb / Pixabay

Nucala Recommended for Three New Indications

Nucala has already been approved in Europe as an add-on treatment for patients with extreme eosinophilic asthma. Now, the EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended…

Continue Reading Nucala Recommended for Three New Indications